Memorial Sloan Kettering provides expert care for people with rare blood disorders. Our depth of experience means that you get the best possible care no matter how uncommon your disease. Our physicians have great familiarity with the treatment of these disorders and their complications, and with deciding which therapies are appropriate.
Every patient receives personalized care from a multidisciplinary team of specialists, which may include experts in hematology, radiology, pathology, bone marrow transplantation, and pain management.
Our team meets regularly to discuss your diagnosis and works collaboratively to develop a treatment plan tailored to the stage of your disease. The involvement of specialists from many different disciplines ensures that we consider all possible approaches and that you receive the best combination of treatments.
In addition, our nurses specialize in caring for people with blood disorders, maintaining a patient-centered focus, and placing your needs and preferences first. They collaborate with your doctors as part of your disease management team and administer therapies, monitor your treatment, watch for side effects, and offer emotional support.
Doctors at Memorial Sloan Kettering also work as lead investigators of clinical trials studying new therapies and diagnostic methods for rare blood disorders. This means that in addition to receiving outstanding care, many of our patients have the opportunity to take advantage of treatments and diagnostic approaches that are not widely available.
Learn more about how we diagnose and treat myeloproliferative diseases (also called myeloproliferative neoplasms) and other rare blood disorders.
- Diagnosis & Treatment of Myeloproliferative Diseases
Learn more about our hematologists and other experts who diagnose and treat myeloproliferative disorders, such as polycythemia vera, myelofibrosis, and other blood diseases.
- Diagnosis & Treatment of Other Rare Blood Disorders
Our hematologists are experts in diagnosing and treating the rare blood disorders histiocytosis, paroxysmal nocturnal hemoglobinuria, and systemic mastocytosis.